Clinical Application of Poly(ADP-Ribose) Polymerase Inhibitors in High-Grade Serous Ovarian Cancer

by Parkes, Eileen E., Kennedy, Richard D.
Published in Oncologist (2016)

The role of PTEN as a cancer biomarker

by McCabe, Nuala, Kennedy, Richard D., Prise, Kevin M.
Published in Oncoscience (2016)

When the guardian becomes the enemy: Targeting ATM in PTEN-deficient cancers

by McCabe, Nuala, Walker, Steven M, Kennedy, Richard D
Published in Mol Cell Oncol (2015)

DNA Repair Deficiency in Breast Cancer: Opportunities for Immunotherapy

by Gilmore, Elaine, McCabe, Nuala, Kennedy, Richard D., Parkes, Eileen E.
Published in J Oncol (2019)

The complex relationship between BRCA1 and ERα in hereditary breast cancer

by Gorski, Julia J., Kennedy, Richard D., Hosey, Alison M., Harkin, D. Paul
Published 2009

Molecular Subtypes and Personalized Therapy in Metastatic Colorectal Cancer

by Graham, Donna M., Coyle, Vicky M., Kennedy, Richard D., Wilson, Richard H.
Published in Curr Colorectal Cancer Rep (2016)

CHK1 inhibition as a strategy for targeting fanconi anemia (FA) DNA repair pathway deficient tumors

by Look A Thomas, Sidi Samuel, Kennedy Richard D, Chen Clark C, D'Andrea Alan
Published 2009-04-01

CHK1 inhibition as a strategy for targeting fanconi anemia (FA) DNA repair pathway deficient tumors

by Chen, Clark C, Kennedy, Richard D, Sidi, Samuel, Look, A Thomas, D'Andrea, Alan
Published 2009

Chk1-Mediated Phosphorylation of FANCE Is Required for the Fanconi Anemia/BRCA Pathway

by Wang, XiaoZhe, Kennedy, Richard D., Ray, Kallol, Stuckert, Patricia, Ellenberger, Tom, D'Andrea, Alan D.
Published 2007

Academic Medicine – revolution, evolution or extinction?

by Irwin, Gareth W, Roy Spence, AJ, McAuley, Danny F, Kennedy, Richard D, Gardiner, Keith R, Elborn, J Stuart
Published in Ulster Med J (2014)

IGF-1R inhibition sensitizes breast cancer cells to ATM-related kinase (ATR) inhibitor and cisplatin

by O'Flanagan, Ciara H., O'shea, Sandra, Lyons, Amy, Fogarty, Fionola M., McCabe, Nuala, Kennedy, Richard D., O'Connor, Rosemary
Published in Oncotarget (2016)

Activation of MAPK signalling results in resistance to saracatinib (AZD0530) in ovarian cancer

by McGivern, Niamh, El-Helali, Aya, Mullan, Paul, McNeish, Iain A., Paul Harkin, D., Kennedy, Richard D., McCabe, Nuala
Published in Oncotarget (2017)

The musculoskeletal consequences of latissmus dorsi breast reconstruction in women following mastectomy for breast cancer

by Blackburn, Nicole E., Mc Veigh, Joseph G., Mc Caughan, Eilis M., Kennedy, Richard D., McIntosh, Stuart A., Wilson, Iseult M.
Published in PLoS One (2018)

A DNA-damage immune response assay combined with PET biomarkers predicts response to neo-adjuvant chemotherapy and survival in oesophageal adenocarcinoma

by Foley, Kieran G., Lavery, Anita, Napier, Eoin, Campbell, David, Eatock, Martin M., Kennedy, Richard D., Bradley, Kevin M., Turkington, Richard C.
Published in Sci Rep (2021)

ATM Kinase Inhibition Preferentially Sensitises PTEN-Deficient Prostate Tumour Cells to Ionising Radiation

by Hanna, Conor, Dunne, Victoria L., Walker, Steven M., Butterworth, Karl T., McCabe, Nuala, Waugh, David J. J., Kennedy, Richard D., Prise, Kevin M.
Published in Cancers (Basel) (2020)

CDK1 PARTICIPATES IN BRCA1-DEPENDENT S PHASE CHECKPOINT CONTROL IN RESPONSE TO DNA DAMAGE

by Johnson, Neil, Cai, Dongpo, Kennedy, Richard D., Pathania, Shailja, Arora, Mansi, Li, Yu-Chen, D’Andrea, Alan D., Parvin, Jeffrey D., Shapiro, Geoffrey I.
Published 2009

Fanconi anemia pathway–deficient tumor cells are hypersensitive to inhibition of ataxia telangiectasia mutated

by Kennedy, Richard D., Chen, Clark C., Stuckert, Patricia, Archila, Elyse M., De la Vega, Michelle A., Moreau, Lisa A., Shimamura, Akiko, D’Andrea, Alan D.
Published 2007

Long-range Transcriptome Sequencing Reveals Cancer Cell Growth Regulatory Chimeric mRNA

by Plebani, Roberto, Oliver, Gavin R, Trerotola, Marco, Guerra, Emanuela, Cantanelli, Pamela, Apicella, Luana, Emerson, Andrew, Albiero, Alessandro, Harkin, Paul D, Kennedy, Richard D, Alberti, Saverio
Published 2012

Potentiation of Inflammatory CXCL8 Signalling Sustains Cell Survival in PTEN-deficient Prostate Carcinoma

by Maxwell, Pamela J., Coulter, Jonathan, Walker, Steven M., McKechnie, Melanie, Neisen, Jessica, McCabe, Nuala, Kennedy, Richard D., Salto-Tellez, Manuel, Albanese, Chris, Waugh, David J.J.
Published 2012

BRCA1 is a key regulator of breast differentiation through activation of Notch signalling with implications for anti-endocrine treatment of breast cancers

by Buckley, Niamh E., Nic An tSaoir, Caoimhe B., Blayney, Jaine K., Oram, Lisa C., Crawford, Nyree T., D’Costa, Zenobia C., Quinn, Jennifer E., Kennedy, Richard D., Harkin, D. Paul, Mullan, Paul B.
Published 2013